Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Bolla

Showing results (121-130 of 158) with videos related to

Pageof 16
Sort By:
Critical Reviews in Oncology/Hematology|October 20, 2009
Background for the proposal of SIOG guidelines for the management of prostate cancer in senior adultsJean-Pierre Droz, Lodovico Balducci, Michel Bolla, et al.
ACS Infectious Diseases|May 4, 2026
Oxadiazolone Derivatives: Powerful Tools to Reduce <i>Staphylococcus aureus</i> InfectionEmma Forest, Jordan Lehoux, Léo Faion, et al.
Npj Antimicrobials and Resistance|April 30, 2026
NV716 acts as an envelope-active adjuvant that enhances antibiotic accumulation in Pseudomonas aeruginosaMargot Draveny, Hugo Chauvet, Axelle De Pauw, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 25, 2018
Porin self-association enables cell-to-cell contact in <i>Providencia stuartii</i> floating communitiesMariam El-Khatib, Chady Nasrallah, Julie Lopes, et al.
European Journal of Cancer (Oxford, England : 1990)|May 14, 2014
Recruiting long-term survivors of European Organisation for Research and Treatment of Cancer phase III clinical trials into quality of life studies: challenges and opportunitiesMarieke van Leeuwen, Fabio Efficace, Sophie D Fosså, et al.
Advanced Healthcare Materials|March 11, 2025
Unlocking the Gates: A Novel Diagnostic Molecule for Quantifying Efflux Levels in Gram-Positive BacteriaMrunal Patil, Tatiana Munteanu, Gaël Brasseur, et al.
Lancet (London, England)|August 16, 2005
Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911)Michel Bolla, Hein van Poppel, Laurence Collette, et al.
Lancet (London, England)|July 20, 2002
Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trialMichel Bolla, Laurence Collette, Léo Blank, et al.
The Lancet. Oncology|October 12, 2010
External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised studyMichel Bolla, Geertjan Van Tienhoven, Padraig Warde, et al.
International Journal of Molecular Sciences|March 6, 2021
Molecular Insights into an Antibiotic Enhancer Action of New Morpholine-Containing 5-Arylideneimidazolones in the Fight against MDR BacteriaAneta Kaczor, Karolina Witek, Sabina Podlewska, et al.
Pageof 16

Showing results (121-130 of 158) with videos related to

Sort By:
Pageof 16
Critical Reviews in Oncology/Hematology|October 20, 2009
Background for the proposal of SIOG guidelines for the management of prostate cancer in senior adultsJean-Pierre Droz, Lodovico Balducci, Michel Bolla, et al.
ACS Infectious Diseases|May 4, 2026
Oxadiazolone Derivatives: Powerful Tools to Reduce <i>Staphylococcus aureus</i> InfectionEmma Forest, Jordan Lehoux, Léo Faion, et al.
Npj Antimicrobials and Resistance|April 30, 2026
NV716 acts as an envelope-active adjuvant that enhances antibiotic accumulation in Pseudomonas aeruginosaMargot Draveny, Hugo Chauvet, Axelle De Pauw, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 25, 2018
Porin self-association enables cell-to-cell contact in <i>Providencia stuartii</i> floating communitiesMariam El-Khatib, Chady Nasrallah, Julie Lopes, et al.
European Journal of Cancer (Oxford, England : 1990)|May 14, 2014
Recruiting long-term survivors of European Organisation for Research and Treatment of Cancer phase III clinical trials into quality of life studies: challenges and opportunitiesMarieke van Leeuwen, Fabio Efficace, Sophie D Fosså, et al.
Advanced Healthcare Materials|March 11, 2025
Unlocking the Gates: A Novel Diagnostic Molecule for Quantifying Efflux Levels in Gram-Positive BacteriaMrunal Patil, Tatiana Munteanu, Gaël Brasseur, et al.
Lancet (London, England)|August 16, 2005
Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911)Michel Bolla, Hein van Poppel, Laurence Collette, et al.
Lancet (London, England)|July 20, 2002
Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trialMichel Bolla, Laurence Collette, Léo Blank, et al.
The Lancet. Oncology|October 12, 2010
External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised studyMichel Bolla, Geertjan Van Tienhoven, Padraig Warde, et al.
International Journal of Molecular Sciences|March 6, 2021
Molecular Insights into an Antibiotic Enhancer Action of New Morpholine-Containing 5-Arylideneimidazolones in the Fight against MDR BacteriaAneta Kaczor, Karolina Witek, Sabina Podlewska, et al.
Pageof 16